Company

Fresenius Kabi Oncology Limited develops, manufactures and markets anti-cancer products for critically and chronically ill patients. As a part of the globally reputed Fresenius Healthcare Group, it plays a pivotal role in patient care, both within and outside hospitals, to efficaciously carry forward its mission of “caring for life”.

Fresenius Kabi Oncology Limited has been able to leverage the global outreach in benchmarking oncology excellence with latest world class production, avant-garde manufacturing and Research & Development facilities.

Leveraging the world class expertise for the development and manufacturing of Active Pharmaceutical Ingredients, intermediates and oral & injectable finished dosage forms, Fresenius Kabi Oncology Limited provides high quality and cost effective pharmaceutical products to the markets worldwide. The Company's finished dosage forms are manufactured at the most modern manufacturing units in Baddi (India), while the Active Pharmaceutical Ingredients (APIs) are manufactured at Kalyani (India).

The Company provides high quality products supported by superior level of customer service at highly competitive prices. Its commitment to Quality by Design (QbD) is endorsed by Regulatory Authorities like TGA, EDQM and USFDA. It provides 24X7, 365 days a year service for this challenging therapeutic segment at price points that ensure maximum number of people around the globe avail the treatment. The Company is dedicated to making and marketing well-priced, quality medicines for the treatment of cancer.